טוען...
Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13
IMPORTANCE: Functional end points for clinical trials investigating the efficacy of emerging treatments for Stargardt disease type 1 (STGD1) are needed. OBJECTIVE: To assess the yearly rate of change of macular function in patients with STGD1 using microperimetry. DESIGN, SETTING, AND PARTICIPANTS:...
שמור ב:
| הוצא לאור ב: | JAMA Ophthalmol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Medical Association
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256863/ https://ncbi.nlm.nih.gov/pubmed/32463436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2020.1735 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|